Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
32
PMEDF Quote, Financials, Valuation and Earnings
Last price:
$0.0530
Seasonality move
:
-22.54%
Day range:
$0.0530 - $0.0530
52-week range:
$0.0053 - $0.0670
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
116.89x
P/B ratio:
35.94x
Volume:
50
Avg. volume:
23.9K
1-year change:
386.24%
Market cap:
$11M
Revenue:
--
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Predictmedix AI, Inc. has -- downside to fair value with a price target of -- per share.
PMEDF vs. S&P 500
-
Over the past 5 trading days, Predictmedix AI, Inc. has underperformed the S&P 500 by -7.79% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Predictmedix AI, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Predictmedix AI, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Predictmedix AI, Inc. reported revenues of --.
Earnings Growth
-
Predictmedix AI, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Predictmedix AI, Inc. reported earnings per share of -$0.00.
Enterprise value:
10.7M
EV / Invested capital:
-18.81x
Price / LTM sales:
116.89x
EV / EBIT:
--
EV / Revenue:
125.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-19.61x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$37.9K
Return On Assets:
-335.24%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $3.5K | -- | -- | -- | -- | |
| Gross Profit | -$120.3K | -$116.5K | -$37.9K | -$28.5K | -$3.6K | |
| Operating Income | -$1.9M | -$840.2K | -$726.4K | -$174.1K | -$222.4K | |
| EBITDA | -$1.8M | -$723.7K | -$688.5K | -$145.6K | -$218.8K | |
| Diluted EPS | -$0.01 | -$0.01 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $878.1K | $284.5K | $88.5K | $44.8K | $310.2K | |
| Total Assets | $1.2M | $696.3K | $415.9K | $257.1K | $346.8K | |
| Current Liabilities | $83.2K | $454.6K | $340.2K | $912.6K | $917.4K | |
| Total Liabilities | $83.2K | $454.6K | $340.2K | $912.6K | $917.4K | |
| Total Equity | $1.2M | $241.7K | $75.8K | -$655.4K | -$570.6K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.3M | -$32.6K | -$547.5K | -$5K | -$17.7K | |
| Cash From Investing | -$44.4K | -- | -- | -- | -- | |
| Cash From Financing | $1.3M | -- | $774.6K | -- | $159.3K | |
| Free Cash Flow | -$1.3M | -$32.7K | -$547.5K | -$5K | -$17.7K | |
PMEDF
Sector
Market Cap
$11M
--
Price % of 52-Week High
79.1%
--
Dividend Yield
0%
--
Shareholder Yield
-14.17%
--
1-Year Price Total Return
386.24%
--
Beta (5-Year)
0.811
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0560
200-day SMA
Buy
Level
$0.0264
Bollinger Bands (100)
Buy
Level
0.013 - 0.053
Chaikin Money Flow
Sell
Level
-1.8K
20-day SMA
Sell
Level
$0.0575
Relative Strength Index (RSI14)
Buy
Level
50.6368
ADX Line
Sell
Level
18.2116
Williams %R
Neutral
Level
-66.6667
50-day SMA
Buy
Level
$0.0425
MACD (12, 26)
Buy
Level
0.0144
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Sell
Level
-3.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-157.1256)
Sell
CA Score
(Annual)
Level (-27.3921)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (95.1519)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (0)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Predictmedix AI, Inc. is a life sciences technology company, which engages in developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. It provides tools for medical professionals. The company was founded on September 3, 1987 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, PMEDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PMEDF average analyst price target in the past 3 months is --.
-
Where Will Predictmedix AI, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Predictmedix AI, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Predictmedix AI, Inc.?
Analysts are divided on their view about Predictmedix AI, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Predictmedix AI, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Predictmedix AI, Inc.'s Price Target?
The price target for Predictmedix AI, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PMEDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Predictmedix AI, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PMEDF?
You can purchase shares of Predictmedix AI, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Predictmedix AI, Inc. shares.
-
What Is The Predictmedix AI, Inc. Share Price Today?
Predictmedix AI, Inc. was last trading at $0.0530 per share. This represents the most recent stock quote for Predictmedix AI, Inc.. Yesterday, Predictmedix AI, Inc. closed at $0.0530 per share.
-
How To Buy Predictmedix AI, Inc. Stock Online?
In order to purchase Predictmedix AI, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get PMEDF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PMEDF
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
35.94x
--
Price / LTM sales
116.89x
--
Growth Metrics
PMEDF
Sector
Revenue growth
--
--
Earnings growth
8.33%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
PMEDF
Sector
Profitability FY 2024
-$112.7K
--
Return on invested capital
--
--
Return on assets
-335.24%
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
PMEDF
Sector
Total cash
$223.9K
--
Short term investments
--
--
Total assets
$91.1K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
